Dyne Therapeutics, Inc.
DYN
Jodie situation report
Dyne Therapeutics, Inc.'s move is being confirmed by its market group.
DYN accounts for 5.1% of the group's measured movement across 8.4 effective names. raw member direction is mixed; 8 of 12 session-normalized paths align to the upside. Capital-flow agreement is 17%, so confirmation is not yet clean. No verified headline preceded the measured group move.
Is this move genuinely shared?
MIRM, BLTE, ARQT moved materially before DYN. DYN crossed its material path threshold at 15:35 ET.
14 of 18 members in Biotech Rare Diseases are active. 0 of 3 disclosed connections are confirming.
- At least 12 of 18 members remain active in the next snapshot.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as ROIV begins moving with the group.
Invalidation: The live read weakens if participation falls to 6 of 18 members or fewer.
Who this business touches
The relationships behind DYN
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
HTGCHercules Capital, Inc.lenderMay 11, 2026 ▾
“To date, we have principally raised capital through sales of equity securities and our borrowing under our Loan and Security Agreement, or the Loan Agreement, with Hercules Capital, Inc., or Hercules.”
ALNYAlnylam Pharmaceuticals, Inc.competitorMay 11, 2026 ▾
“We also expect to compete more generally with other companies developing alternative scientific and technological approaches to the treatment of muscle diseases, including other companies working to develop conjugates with oligonucleotides for extra-hepatic d…”
Depended on by
BMRNBioMarin Pharmaceutical Inc.competitorFeb 26, 2026 ▾
“In addition, BMN 351 could have potential competition from clinical product candidates for exon 51 skipping amenable DMD by Dyne Therapeutics, Inc.”
Filing peers
No filing peers are available for this name yet.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
DYN is currently a Participant in the organic co-movement group Biotech Rare Diseases. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.